Form 4: Xos Director Sells Shares Under 10b5-1 Plan

Xos, Inc. Director Dietmar Ostermann sold 11,478 shares of common stock across three transactions in December 2025, pursuant to a pre-arranged 10b5-1 trading plan.

Summary

• Dietmar Ostermann, a Director of Xos, Inc. (XOS), reported the sale of common stock.
• The transactions were executed under a Rule 10b5-1 trading plan adopted on September 16, 2025.
• On December 18, 2025, 3,826 shares were sold at a weighted average price of $2.0527 per share.
• On December 19, 2025, an additional 3,826 shares were sold at a weighted average price of $2.0361 per share.
• On December 22, 2025, a further 3,826 shares were sold at a weighted average price of $2.1391 per share.
• The total number of shares sold across these three dates is 11,478.
• Following these transactions, Dietmar Ostermann beneficially owns 82,944 shares of common stock, which includes 62,377 unvested Restricted Stock Units (RSUs).

Sentiment

Score: 4

Explanation: The filing reports insider selling by a director, which can be perceived as a slightly negative signal, although the sales were conducted under a pre-arranged 10b5-1 trading plan, mitigating some of the immediate concern.

Negatives

• Director Dietmar Ostermann sold 11,478 shares of Xos, Inc. common stock, which can sometimes be perceived as a negative signal by investors, even when pre-scheduled.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Director Dietmar Ostermann sold 11,478 shares of Xos, Inc. common stock.

Stakeholder Impact

• Shareholders: The sale of shares by a director, even under a 10b5-1 plan, could be perceived by some shareholders as a signal of reduced confidence in the company's near-term prospects, potentially influencing stock price sentiment.

Key Dates

Recommendation

The filing details routine insider selling by a director under a pre-arranged 10b5-1 plan. While insider selling can be a negative signal, the pre-scheduled nature mitigates immediate concerns. Without additional company-specific news or broader market context, a 'hold' recommendation is appropriate as this filing alone does not provide sufficient information to alter a fundamental investment thesis.

Keywords

Xos, Inc., XOS, Dietmar Ostermann, insider trading, Form 4, stock sale, 10b5-1 plan, director